Kimberly-Clark Is Buying Tylenol Maker Kenvue for Nearly $49B. Here's What You Need to Know
1. Kimberly-Clark announced a $48.7 billion acquisition of Kenvue. 2. Kenvue shares rose 17%, while Kimberly-Clark shares fell 13%. 3. Kenvue investors will receive $3.50 cash and KMB shares in exchange. 4. CEO mentions portfolio transformation to higher-growth businesses. 5. Both companies have faced declines in stock value this year.